Spontaneous proliferation in vitro is a notable characteristic of freshly isolated peripheral blood mononuclear cells (PBMCs) from individuals with human T-cell leukemia virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAMFTSP) and asymptomatic HTLV-I carriers (19, 20, 39) . The association of HTLV-I gene expression with this immune activation (16, 39) and detection of viral DNA in the blood T-cell population (32) suggest that infected T cells regulate this proliferation. The HTLV-I regulatory protein Tax and the extracellular domain of the envelope protein gp46 may have critical roles in the spontaneous proliferation of PBMCs. First, since the proliferation of PBMCs is interleukin-2 (IL-2) dependent and associated with HTLV-I gene expression, it has been suggested that Tax stimulates an autocrine growth loop by trans activating IL-2 and its receptor (39) . Tax has been shown to trans activate these two genes and several others (e.g., c-fos, the granulocyte-macrophage colony-stimulating factor gene, c-myc, and the major histocompatibility complex protein class I and II genes) that are commonly associated with the early stage of T-cell activation (13, 14, 26, 34, 36, 41) . Second, virus particles concentrated from conditioned supernatants of HTLV-I-producing T-cell lines have been shown to activate T cells by direct contact (15) . HTLV-I patient antisera and a monoclonal antibody (MAb), 0.5 * Corresponding author. alpha, against gp46 neutralize the mitogenic activity of the virus, suggesting that gp46 is a T-cell mitogen.
We have demonstrated that an HTLV-I-producing T-cell line induces an IL-2 dependent proliferation of peripheral blood T cells during the early stage of in vitro immortalization and that infection of the responder cells and secretion of a soluble factor by the HTLV-I-producing cells are not prerequisites for activation (22) . Cell-to-cell contact was found to be sufficient for T-cell activation. This observation led us to hypothesize that cell surface contact between HTLV-I-expressing T cells and resting T cells may be important for activation of proliferative responses not only in the early stages of T-lymphocyte infection and immortalization but also in the spontaneous proliferation observed in PBMCs from HTLV-I-infected asymptomatic carriers and individuals with HAM/TSP. Therefore, we evaluated the contribution of viral particles and cell contact to T-lymphocyte activation by examining the ability of purified HTLV-I particles and infected T-cell and non-T-cell lines to induce proliferation of peripheral blood lymphocytes (PBLs) and to induce IL-2 mRNA expression in the leukemic cell line Jurkat. Furthermore, we attempted to define the possible cellular and viral proteins that may be involved in this activation process by using MAbs and antisera against several viral proteins and cellular adhesion molecules known to modulate T-cell activation. The results suggest that the mitogenic activity is associated with virus-producing T cells and mediated in part via the CD2/lymphocyte functionassociated antigen 3 (LFA-3) activation pathway.
T-CELL ACTIVATION BY HTLV-I

MATERIALS AND METHODS
Cell lines and culture. HTLV-I-positive T-cell lines MT2, HUT102, and MT4 as well as the uninfected T-cell lines H9, HUT78, and Jurkat 25 (kindly provided by S. Luria and P. Berg) were maintained in RPMI 1640 medium containing 10% heat-inactivated fetal bovine serum, 2 mM glutamine, 100 U of penicillin per ml, and 100 p,g of streptomycin per ml (RPMI complete). The HTLV-I-infected HOS/PL cell line and the parental HOS line (8) were passaged in Dulbecco's modified Eagle's medium with high glucose (4.5 g/liter), 10% heat-inactivated fetal bovine serum, 1 mM sodium pyruvate, 2 mM glutamine, penicillin, and streptomycin.
Antisera and MAbs. Generation and analysis of reactivity of rabbit antisera against synthetic peptides of hydrophilic regions of the HTLV-I envelope glycoproteins gp46 and gp2l have been previously described (29, 30) . MAbs against gp46 have been previously described: LAT-27 (1 mg/ml) and REY-30 (1 mg/ml) (generously provided by Y. Tanaka [38] ) and 0.5 alpha (2 mg/ml) (provided by S. Matsushita [27] ). The anti-Tax (1 mg/ml) antibody was a gift of R. Gartenhaus. Antiserum to IL-2 was purchased from Genzyme. Leu Virus concentration and purification by sucrose density sedimentation. Virus particles were purified by a modification of the method of Ratner et al. (31) . Conditioned supernatants from the HTLV-I-producing cell lines HOS/PL and MT2 were clarified by centrifugation at 2,000 rpm for 10 min at 4°C. The supernatants were then spun at 20,000 rpm in a Beckman SW28 rotor for 2.5 h at 4°C. Supernatants were removed, and the pellets were resuspended in STE (10 mM Tris [pH 7.4] , 100 mM NaCl, 1 (22) . The viable cell number was determined by trypan blue exclusion. trifugation (Fig. 1A) . HTLV-I gag protein p199a9 was detected in fractions 15 to 17. These fractions had a density of 1.15 to 1.16 g/ml, a range similar to values previously reported for HTLV-I particles (35) . This finding indicated that the majority of p199a9 found in culture supernatants was virion associated. The envelope protein gp46 was detected in fractions 15 to 17 as well as in fraction 30 (top of the gradient) by immunoblotting (Fig. 1B) , indicating that gp46 was also virion associated but that some may have been stripped off during the purification process.
We compared the purified virus particles (MT2 particles) with concentrated virus particles from MT2 and HOS/PL cells for the ability to activate PBLs by [3H]thymidine incorporation and viable cell number ( Fig. 1C and D) . The inset to Fig. 1C shows that 4-day conditioned supernatant of HOS/PL cells contained amounts of the viral structural proteins pl9gag, p249a&, and gp46 similar to those found in 3-day conditioned supernatants from the MT2 cell line. We confirmed the presence of virus particles in the HOS/PL supernatants by sucrose density centrifugation (data not shown). Purified virions (5 ,ug of p199a9 per ml) did not induce either thymidine incorporation or an increase in cell number. In contrast, an equal amount of p199a9 concentrated from MT2 supernatant by ultracentrifugation increased thymidine incorporation 10-fold over unstimulated PBLs (2, 417 + 541 cpm versus 235 + 30 cpm); this level was 10-fold less than the proliferation induced by PHA (26,700 + 2,092 cpm). Furthermore, neither pelleted material from an equal amount of conditioned supernatant of the HTLV-I-negative mature T-cell line (IL-2 receptor', HLA-DR+) HUT78 (17) nor HTLV-I particles from the HTLV-I-producing human osteosarcoma cell line HOS/PL (5 j±g of p199a9 per ml) induced proliferation of PBLs. Virus from HOS/PL also did not induce an increase in viable cell number.
In contrast to the purified virions, HTLV-I-producing T-cell lines induced proliferation of PBLs (Fig. 1E) (15) , and LAT-27 inhibits syncytium formation and infection of T lymphocytes by HTLV-I at concentrations of 2.5 and 10 ,ug/ml, respectively (38) . Anti-synthetic peptide antiserum to amino acids 86 to 107 (anti-SP-2) at a dilution as low as 1:10 was not inhibitory (data not shown). Although the antienvelope antibodies (anti-SP-2, anti-SP-4A, 0.5 alpha, and LAT-27) did not inhibit T-cell proliferation at neutralizing conditions, they were capable of binding envelope protein on immunoblot assays (Fig. 1B and data not shown) . Lastly, the anti-Tax antibody (10 ,ug/ml, final concentration) also did not inhibit proliferation, though this concentration of antibody neutralizes the activity of a soluble form of Tax.
Anti-CD2 and anti-LFA-3 inhibit HTLV-I-induced proliferation of PBLs. Antigen-specific activation of T cells occurs through the T-cell receptor (TCR) (9, 42 (Fig. 3A and B) . MT2 and HUT102 cells induced IL-2 mRNA expression greater than 1,000-fold over unstimulated Jurkat 25 cells. In contrast, HUT78 cells did not induce IL-2 mRNA expression. Interestingly, anti-CD2 (TS2/18) and anti-LFA-3 (TS2/9) blocked expression of IL-2 mRNA. Anti-ICAM-1 (RR1/1), anti-LFA-1 (TS1/22), anti-HLA-DR, and anti-CD4 did not inhibit expression. The inhibition by anti-CD2 and anti-LFA-3 was not due to negative signalling, as these MAbs did not inhibit activation of Jurkat 25 cells by PHA and PMA or Leu 4 (anti-CD3) plus PMA (Fig. 3D) .
To determine which of the adhesion molecules on the HTLV-I-producing cell lines were mediating the activation of Jurkat cells, we preincubated the MAbs with MT2 cells and removed the excess antibodies by washing the cells twice with PBS prior to fixation. Figure 3C shows that in comparison with the negative control mouse immunoglobulin G, anti-LFA-3 (TS2/9) inhibited IL-2 mRNA expression approximately 90-fold. None of the other antibodies had a negative effect. Hence, as with HTLV-I-induced proliferation of PBLs, activation of Jurkat 25 cells to express IL-2 mRNA by HTLV-I is T-cell associated and mediated by the CD2/LFA-3 pathway. Antibodies directed to gp46, gp2l, p4O', p199'9, and TSP patient antisera did not inhibit activation of Jurkat cells by HTLV-I-infected cells or concentrated virus particles from MT2 cells (data not shown).
DISCUSSION
In this study, we have examined the mitogenic activity of HTLV-I by using concentrated and sucrose gradient-purified viral particles as well as virus-producing cell lines. Gazzolo and Duc Dudon reported that concentrated viral particles can directly activate resting T lymphocytes and that the envelope protein gp46 mediates this effect (15) . While we also find that concentrated virus produced from a T-cell line acts as a weak mitogen for PBLs, the same virus strain after sucrose gradient purification is incapable of stimulating proliferation. Furthermore, we demonstrate the presence of gp46 on purified viral particles; this finding indicates that the lack of stimulation cannot be accounted for by an absence of gp46 due to stripping during the purification process. In light of these data, we conclude that virion-associated gp46 is not a T-cell mitogen. Lastly, the inability of concentrated virus from HOSIPL cells to induce proliferation of PBLs confirms that HTLV-I virions are not intrinsically mitogenic.
A possible explanation for these results is that an inhibitor of the mitogenic activity is present in purified virus particles from MT2 cells and concentrated virions from HOSWPL cells but absent from concentrated virus particles from the MT2 cell line. Although we cannot completely exclude this as an explanation, we feel that it is a remote possibility.
As we and others have shown (22, 44) and we have demonstrated here, the HTLV-I-associated mitogenic activity is cell associated, requires direct cell contact, and is IL-2 dependent. In this study, we also show that the type of virus-producing cell is important: only the HTLV-I-infected (27, 30, 38 Adhesion molecules other than CD2/LFA-3 and LFA-1/ ICAM-1 play a role in costimulating T-cell activation through the CD3/TCR complex, including V-CAM-1/VLA-4/I,3 integrin and B7/CD28 (10). We have not tested antibodies against these adhesion proteins and therefore cannot rule out their potential participation in lymphocyte activation by HTLV-I. However, the fact that anti-LFA-3 and anti-CD2 strongly block proliferation of PBLs induced by HTLV-Iinfected T cells (80 and 93%, respectively) and completely block activation of IL-2 mRNA expression in Jurkat cells demonstrates that the CD2 pathway plays a central role in this activation. Furthermore, T-cell activation via CD2 can occur without engagement of the CD3/TCR complex (3, 4, 12, 18, 28) . We found that anti-HLA-DR and anti-CD4 did not inhibit IL-2 mRNA expression in Jurkat cells. However, we cannot completely rule out ligand engagement with the CD3/TCR complex. We have tested the ability of HTLV-Iinfected T cells to activate IL-2 mRNA expression in a mutant CD3-CD2+ Jurkat cell line. As others have shown with different stimuli (3), we have found that activation by HTLV-I infected T cells requires the expression of the CD3/TCR complex (23) .
Although it does not appear that either the envelope glycoprotein gp46 or gp2l or extracellular Tax protein is mediating T-cell activation by HTLV-I-infected T cells, another viral protein or trans activation of cellular genes by Tax may be important for conferring this activity upon infected T cells. Brod et al. (4) have shown that early after activation, T cells could stimulate proliferation of resting T cells in an autologous reaction. Presumably, this occurred in an antigen-independent fashion. Interestingly, Kelly et al. (21) have demonstrated that HTLV-I infection of T cells stabilizes an early-activation phenotype which is normally transient. They suggest that Tax and perhaps other pXencoded proteins modulate the cell state. In the context of these data, it may be that the mitogenic activity of HTLV-I-infected T cells results from maintaining an early-activation phenotype via expression of a viral regulatory gene product(s).
On the other hand, as LFA-3 alone does not activate T cells (12) , a viral protein involved in virus-cell interactions might act as a costimulator of T-cell activation with LFA-3. Several open reading frames capable of encoding novel proteins have been reported for HTLV-I (1, 7, 24). Koralnik et al. (24) speculate that these potential proteins may have roles in regulating viral replication and in virus-cell interactions. Determining the function of these potential proteins and construction of a replication-competent molecular clone of HTLV-I may provide insight into which viral genes are involved in conferring the mitogenic activity and the mechanism of T-cell activation via direct cell contact between infected and uninfected T cells. In any case, in addition to trans activation of cytokine genes by Tax, T-lymphocyte activation by cell-to-cell contact may be another mechanism by which HTLV-I infection contributes to the immune activation observed in HTLV-I-infected asymptomatic and HAM/TSP patients.
